NYSE· Finance Services· Inc. NY· CIK 0000004962

AXP

AMERICAN EXPRESS CO
$301.62 ▼ -0.16%
Prev close $302.09
Market cap$206.2B
ConsensusHold
12-mo target$375.83 (+24.6%)
▲ Neutral
Analyst conviction 5/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)29 New Institutional Positions21 Institutional Exits Traditional Finance
Snapshot
The big-picture read on AXP right now — valuation, ownership and activity at a glance.
Market Cap
$206.2B
Cap Size
Mega Cap
Analyst Consensus
Buy (54%)
Inst. Holders
50 funds
Inst. Value
$155.1B
Inst. Activity
29 buys / 21 sells
Insider Activity
$0.00 buy / $37.0M sell
Insider Net $
-$37.0M
Social Sentiment
58° Warm
SEC Reports
20
Congressional
5 trades
Price chart 30d -8.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 short_volume
Short Volume: AXP — 56.1% short (0.7M / 1.2M)
Short: 668,060 | Exempt: 1,428 | TRF Vol: 1,190,802 | Short Ratio: 56.1% | Off-exchange volume (dark
Sep 16, 2026 Event
Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01
Class I: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter ident
Sep 14, 2026 Event
Turner v. American Express Company et al
Court ruling (mdd) — Docket: 1:25-cv-02365
Aug 18, 2026 Insider
Herena Monique sold 8,811 shares
Chief Colleague Exp. Officer @ $337.41 ($3.0M)
Jul 13, 2026 SEC
JP Morgan double upgrades AXP to Overweight — PT $400 (+14.1%)
ANALYST-UPGRADE — Impact 3/10
Jun 30, 2026 SEC
Piper Sandler initiates AXP at Overweight — PT $396 (+16%)
ANALYST-UPGRADE — Impact 1/10
Jun 30, 2026 Insider
PHILLIPS JR CHARLES E was granted 56.131 shares
Director @ $334.04 ($18.7K)
Jun 30, 2026 Insider
Young Christopher David was granted 119.746 shares
Director @ $334.04 ($40.0K)
Analyst ratings buy % +38.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Hold 54% rate it Buy or better · 37 analysts
Strong Buy 5 14% Buy 15 41% Hold 16 43% Sell 0 0% Strong Sell 1 3%
Recent analyst actions
DateFirmActionRatingFirm rating
Oct 1, 2026Evercore ISI GroupMAINTAINIn-Line 59%
Sep 30, 2026CitigroupMAINTAINNeutral 55%
Sep 23, 2026Truist SecuritiesMAINTAINBuy 55%
Aug 12, 2026Piper SandlerMAINTAINOverweight 54%
Aug 3, 2026UBSMAINTAINNeutral 55%
Jul 27, 2026Morgan StanleyMAINTAINEqual-Weight 55%
Jul 27, 2026Evercore ISI GroupMAINTAINIn-Line 59%
Jul 27, 2026BTIGMAINTAINSell 53%
Jul 13, 2026HSBCMAINTAINHold 55%
Jul 13, 2026JP MorganUPGRADEOverweight 55%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 2026515160154%
Aug 1, 2026515160154%
Jul 1, 2026513170150%
Jun 1, 2026412180146%
May 1, 2026511180146%
Apr 1, 2026511180146%
Mar 1, 2026510190143%
Feb 1, 2026510200142%
Price targets
Where 24 covering analysts think AXP trades over the next 12 months.
$375.83 +24.6% upside Strong Buy
Current$301.62 Low$320.00 Median$383.00 High$450.00 24 analysts
$320.00$450.00
Analyst rating Buy· 2.2/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
58°
Warm
BearishNeutralBullish
15 mentions 7 bullish 4 bearish 4 neutral
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 3 bullish, 1 bearish, 2 mixed, 14 neutral · avg impact 2.3/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 29, 2026
short_volume
Short Volume: AXP — 56.1% short (0.7M / 1.2M)
Short: 668,060 | Exempt: 1,428 | TRF Vol: 1,190,802 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: AXP — 57.8% short (0.8M / 1.4M)
Short: 827,490 | Exempt: 39 | TRF Vol: 1,432,093 | Short Ratio: 57.8% | Off-exchange volume (dark pool + OTC)
Sep 16, 2026
FDA
Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01
Class I: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene
Sep 14, 2026
short_volume
Short Volume: AXP — 56.5% short (0.4M / 0.8M)
Short: 433,527 | Exempt: 2,657 | TRF Vol: 766,801 | Short Ratio: 56.5% | Off-exchange volume (dark pool + OTC)
Sep 14, 2026
Enforcement
Turner v. American Express Company et al
Court ruling (mdd) — Docket: 1:25-cv-02365
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$4.58$4.32–$5.6310.6%-0.2%5↑ 17↓$20.1B23
Next Q$4.29$4.12–$4.5021.4%-0.0%7↑ 14↓$20.8B22
Current FY$17.68$17.40–$18.6215.0%+0.0%8↑ 15↓$79.5B27
Next FY$20.15$19.25–$20.5013.9%+0.2%9↑ 14↓$86.7B27
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$4.577—
7d ago$4.602-0.025
30d ago$4.587-0.010
60d ago$4.593-0.016
90d ago$4.685-0.108
Institutional ownership
Which big funds own AXP (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $155.1B total value (454,598,416 shares) as of 2026-Q2. Top holders: BERKSHIRE, BlackRock,, VANGUARD. Net buying activity: 29 institutions added/increased vs 21 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BERKSHIRE HATHAWAY INC151,610,700$51.3B33.1%—
BlackRock, Inc.42,006,392$14.2B9.2%—
VANGUARD CAPITAL MANAGEMENT LLC35,215,521$11.9B7.7%—
STATE STREET CORP29,095,803$9.8B6.3%—
JPMORGAN CHASE & CO20,459,941$7.0B4.5%—
GEODE CAPITAL MANAGEMENT, LLC14,019,549$4.7B3.0%—
MORGAN STANLEY13,121,109$4.4B2.9%—
Fisher Asset Management, LLC9,426,671$3.2B2.1%—
VANGUARD PORTFOLIO MANAGEMENT LLC8,739,519$3.0B1.9%—
NORGES BANK7,985,867$2.7B1.7%NEW
Recent position changes
FundActionPrevCurrentChangeValue
NORGES BANKNEW—7,985,867—$2.7B
FMR LLCTRIM9,264,9986,007,554-35.2%$2.0B
AMERIPRISE FINANCIAL INCTRIM3,213,9552,394,292-25.5%$810.0M
Capital World InvestorsTRIM2,839,2572,094,222-26.2%$708.4M
MARSHALL WACE, LLPDOUBLED126,0431,429,163+1033.9%$483.4M
TD ASSET MANAGEMENT INCTRIM1,698,0931,214,293-28.5%$410.7M
CITIGROUP INCTRIM1,091,479816,334-25.2%$276.1M
Corient Private Wealth LPDOUBLED805,7104,771,292+492.2%$253.4M
Capital Research Global InvestorsNEAR_EXIT3,170,551741,644-76.6%$250.9M
CIBC Bancorp USA Inc.ADD409,740577,898+41.0%$195.4M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
23 insiders, 50 transactions. Net -$37.0M — $0.00 bought, $37.0M sold.
DateInsiderTitleTypeSharesPriceValue
Aug 18, 2026Herena MoniqueChief Colleague Exp. OfficerSELL8,811$337.41$3.0M
Jun 30, 2026PHILLIPS JR CHARLES EDirectorAWARD56.131$334.04$18.7K
Jun 30, 2026Young Christopher DavidDirectorAWARD119.746$334.04$40.0K
Jun 30, 2026Baltimore Thomas J JrDirectorAWARD108.52$334.04$36.3K
Jun 30, 2026Angelakis Michael JDirectorAWARD54.26$334.04$18.1K
Jun 30, 2026WARDELL LISA WDirectorAWARD112.262$334.04$37.5K
Jun 30, 2026Brennan John JosephDirectorAWARD198.33$334.04$66.3K
Jun 30, 2026Wallace Noel R.DirectorAWARD108.52$334.04$36.3K
Jun 30, 2026Majoras Deborah PDirectorAWARD54.26$334.04$18.1K
Jun 15, 2026McNeal Glenda GChief Partner OfficerSELL7,033$339.36$2.4M
Congressional trades
AXP trades disclosed by members of Congress, with disclosure delay.
5 members · 4 buys / 1 sells
DateMemberPartyChamberTypeAmountAssetDisclosed
May 8, 2026Rick AllenRHOUSEBUY$1,001 - $15,000American Express CoJun 17, 2026(41d)
Apr 7, 2026Rick LarsenDHOUSESELL$1,001 - $15,000American Express CoApr 16, 2026(10d)
Mar 31, 2026Jared MoskowitzDHOUSEBUY$1,001 - $15,000American Express CoMay 1, 2026(32d)
Mar 11, 2026Shelley Moore CapitoRSENATEBUY$1,001 - $15,000American Express CoApr 5, 2026(26d)
Dec 29, 2025Markwayne MullinRSENATEBUY$1,001 - $15,000American Express CoJan 16, 2026(19d)
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for AXP.
Shares short
10,777,036
Settlement Sep 15, 2026
Change vs prior
+3.4%
Semi-monthly cycle
Days to cover
4.7
At avg daily volume
Of shares outstanding
≈1.6%
Estimate — not % of float
All AXP filing & press-release reports (31)